YRC Freight Honored as FreightCenter’s 2019 Diamond Partner of the Year
OVERLAND PARK, Kan., July 30, 2020 (GLOBE NEWSWIRE) — (NASDAQ: YRCW) YRC Freight has received the FreightCenter 2019 Diamond Partner […]
Precipio Announces Commercial Launch of COVID-19 Antibody Test
NEW HAVEN, Conn., July 30, 2020 (GLOBE NEWSWIRE) — Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), is announcing its COVID-19 […]
DMC Global Announces Promotion of Antoine Nobili to President of NobelClad
BROOMFIELD, Colo., July 30, 2020 (GLOBE NEWSWIRE) — DMC Global Inc. (Nasdaq: BOOM) today announced the promotion of Antoine Nobili […]
Liquid Media to Add More Virtual Reality Content to Streaming Platform in Partnership with YDX Innovation
VANCOUVER, British Columbia, July 30, 2020 (GLOBE NEWSWIRE) — Liquid Media Group Ltd. (the “Company”, “Liquid Media” or “Liquid”) (Nasdaq: […]
UPDATE — EHang to Expand Production Facility for Autonomous Aerial Vehicles
GUANGZHOU, China, July 30, 2020 (GLOBE NEWSWIRE) — EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading […]
Capitala Group Announces New Hires as it Expands its Underwriting and Investor Relations Teams
CHARLOTTE, N.C., July 30, 2020 (GLOBE NEWSWIRE) — Capitala Group (“Capitala”), a leading provider of capital to lower middle market […]
Datametrex Initiates OTCQB Application
TORONTO, July 30, 2020 (GLOBE NEWSWIRE) — Datametrex AI Limited (“Datametrex” or the “Company“) (TSXV: DM, FSE: D4G, OTC: DTMXF) […]
Fidelity D & D Bancorp, Inc. Announces Third Quarter Dividend and Reports Second Quarter 2020 Financial Results
DUNMORE, PA , July 30, 2020 (GLOBE NEWSWIRE) — Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) and its banking […]
Atossa Therapeutics Announces Findings from FDA-Approved Expanded Access Treatment with Endoxifen
SEATTLE, July 30, 2020 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and […]
Salarius Announces Pricing of $5.3 Million Underwritten Public Offering
HOUSTON, July 30, 2020 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting cancers caused by […]
